Dolby Laboratories Inc
For the period ended Dec 29, 2023. Filed Feb 2, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Dec 29, 2023 · Filed Feb 2, 2024
DLB$64.67-0.2%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Unaudited Interim Condensed Consolidated Statements of Comprehensive Income
INTERIM CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
| Fiscal Quarter Ended | ||
|---|---|---|
| December 29,2023 | December 30,2022 | |
| Net income including noncontrolling interest | $67,581 | $79,448 |
| Other comprehensive income: | ||
| Currency translation adjustments gains, net of tax benefit/(expense) of $0 and $0 | 11,649 | 14,381 |
| Unrealized gains on investments, net of tax benefit of $12 and $37 | 1,956 | 1,356 |
| Unrealized gains on cash flow hedges, net of tax benefit/(expense) of ($684) and $156 | 2,091 | 4,332 |
| Total other comprehensive income, net of tax | 15,696 | 20,069 |
| Total comprehensive income | 83,277 | 99,517 |
| Less: comprehensive income attributable to noncontrolling interest | (740) | (376) |
| Comprehensive income attributable to Dolby Laboratories, Inc. | $82,537 | $99,141 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.